Chamber and committees

Further to Parliament’s approval of the 2025-26 Scottish Budget on 25 February 2025, the Scottish Government has been engaging closely with NHS boards to support the allocation of resource for new specialist support for Long COVID, Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) and other similar conditions.

Boards told us that having funding only for a single financial year would be a barrier to their ability to develop new support. Therefore, following further assessment in line with Scottish Government spending controls, we wrote to NHS Board Chief Executives on 18 September to confirm that this funding will now be made available on a recurring basis. This commitment provides the longer term assurance necessary to enable boards to plan on a sustainable basis, and support the recruitment and retention of the skilled members of staff required for the delivery of services.

NHS Boards’ shares of the available 2025-26 funding will be allocated in full on an recurring basis. From the financial year 2026-27 onwards NHS Boards will receive the £4.5 million resource annually.

In 2025-26 the £4.5 million funding is being provided in addition to remaining resource of approximately £3 million from the £10 million long COVID Support Fund (established 2022). The £10 million fund will be fully disbursed by the end of the 2025-26 financial year.

A breakdown is as follows: